NLRP3 and neoplasm: This resulted in reduced melanoma tumour progression (p < 0.01) (Tengesdal et al. 2021) and while not yet been observed in OC, it is possible that the NLRP3 inflammasome drives a complex pro-inflammatory and pro-tumour environment.